Question 1

How does Caralluma fimbriata work to suppress appetite?

Accepted Answer

Caralluma fimbriata contains pregnane glycosides that are believed to suppress appetite by influencing the hypothalamus, the brain region that regulates hunger signals. These compounds may block the activity of citrate lyase, an enzyme involved in fatty acid synthesis, which could contribute to reduced fat storage. Additionally, the plant's active compounds may increase serotonin levels, promoting feelings of fullness and satiety. This dual mechanism helps reduce caloric intake. Evidence level: C (preliminary clinical evidence).

Question 2

Does Caralluma fimbriata interact with diabetes medications?

Accepted Answer

Caralluma fimbriata may interact with diabetes medications due to its potential blood sugar-lowering effects. Combining it with antidiabetic drugs like metformin, insulin, or sulfonylureas could increase the risk of hypoglycemia (low blood sugar). Additionally, its appetite-suppressing properties may alter food intake, which can affect blood glucose management in diabetic patients. Patients with diabetes should consult a healthcare provider before using Caralluma supplements and monitor blood sugar levels closely. Evidence level: C.

Question 3

What is the recommended dosage for Caralluma fimbriata extract?

Accepted Answer

The typical adult dosage for Caralluma fimbriata is 500mg to 1 gram of standardized extract taken twice daily, usually before meals. Clinical studies have used doses in this range for weight management over periods of 8-12 weeks. Standardized extracts containing pregnane glycosides are preferred for consistent potency. It is important not to exceed recommended doses, as long-term safety data beyond 12 weeks is limited. Evidence level: C.

Question 4

Is Caralluma fimbriata safe to take during pregnancy?

Accepted Answer

Caralluma fimbriata is considered unsafe during pregnancy and should be avoided. There is insufficient safety data regarding its effects on fetal development, and its appetite-suppressing properties could interfere with adequate maternal nutrition and weight gain required during pregnancy. Breastfeeding women should also avoid this supplement, as there is no data on whether compounds pass into breast milk. This herb is also contraindicated for children. Evidence level: C (based on traditional use contraindications).

Question 5

What are the common side effects of Caralluma fimbriata?

Accepted Answer

Common side effects of Caralluma fimbriata include nausea, mild digestive upset, stomach discomfort, and intestinal gas. Some users report constipation or changes in bowel movements. These effects are typically mild and often subside after several days of use as the body adjusts. Side effects are more likely when starting supplementation or taking higher doses. Discontinue use if severe gastrointestinal symptoms or allergic reactions occur. Evidence level: C.

Caralluma Fimbriata

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Grossesse et allaitement

Synthèse des preuves

Sources PubMed

Sources gouvernementales